Evidence map›Paper›PMID 25490520›Full record

ArticleBioconjugate chemistry2015

Fluorogen activating protein-affibody probes: modular, no-wash measurement of epidermal growth factor receptors.

Yi Wang, Cheryl A Telmer, Brigitte F Schmidt, Josef D Franke, Stephan Ort, Donna J Arndt-Jovin, Marcel P Bruchez

Open access · greenAbstract read
In one paragraph

Article in Bioconjugate chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Transient Fluorescence Labeling: Low Affinity-High Benefits.International journal of molecular sciences · 2021
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Affibody-targeted fluorogen activating protein for in vivo tumor imaging.Chemical communications (Cambridge, England) · 2017
    Article
  9. Article
  10. Article
  11. Spectral fine tuning of cyanine dyes: electron donor-acceptor substituted analogues of thiazole orange.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2015
    Article
  12. Dark dyes-bright complexes: fluorogenic protein labeling.Current opinion in chemical biology · 2015
    Review
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Yi WangThe Department of Biological Sciences, ‡The Molecular Biosensor and Imaging Center, and ⊥The Department of Chemistry, Carnegie Mellon University , Pittsburgh, Pennsylvania 15213, United States.
Cheryl A Telmer
Brigitte F Schmidt
Josef D Franke
Stephan Ort
Donna J Arndt-Jovin
Marcel P Bruchez
Imaging Center · USCarnegie Mellon University · USMax Planck Institute for Biophysical Chemistry · DE

Funding

Fluorescent Biosensors for Networks and PathwaysU54GM103529 · NIGMS · CARNEGIE-MELLON UNIVERSITY · PI WAGGONER, ALAN S. · 2012 to 2013
$6.3M
Bright Blinking Probes for Fast Multicolor Superresolution Imaging in Live CellsR01GM086237 · NIGMS · CARNEGIE-MELLON UNIVERSITY · PI BRUCHEZ, MARCEL P · 2009 to 2010
$347k
NIGMS NIH HHS R01 GM086237NIGMS NIH HHS R01GM086237NIGMS NIH HHS U54 GM103529NIGMS NIH HHS U54GM103529
6 · The paper itself

Abstract

Fluorescence is essential for dynamic live cell imaging, and affinity reagents are required for quantification of endogenous proteins. Various fluorescent dyes can report on different aspects of biological trafficking, but must be independently conjugated to affinity reagents and characterized for specific biological readouts. Here we present the characterization of a new modular platform for small anti-EGFR affinity probes for studying rapid changes in receptor pools. A protein domain (FAP dL5**) that binds to malachite-green (MG) derivatives for fluorescence activation was expressed as a recombinant fusion to one or two copies of the compact EGFR binding affibody ZEGFR:1907. This is a recombinant and fluorogenic labeling reagent for native EGFR molecules. In vitro fluorescence assays demonstrated that the binding of these dyes to the FAP-affibody fusions produced thousand-fold fluorescence enhancements, with high binding affinity and fast association rates. Flow cytometry assays and fluorescence microscopy demonstrated that these probes label endogenous EGFR on A431 cells without disruption of EGFR function, and low nanomolar surface Kd values were observed with the double-ZEGFR:1907 constructs. The application of light-harvesting fluorogens (dyedrons) significantly improved the detected fluorescence signal. Altering the order of addition of the ligand, probe, and dyes allowed differentiation between surface and endocytotic pools of receptors to reveal the rapid dynamics of endocytic trafficking. Therefore, FAP/affibody coupling provides a new approach to construct compact and modular affinity probes that label endogenous proteins on living cells and can be used for studying rapid changes in receptor pools involved in trafficking.

Indexed as

Cell Line, TumorErbB ReceptorsFluorescent DyesHumansProtein Structure, TertiaryRecombinant Fusion ProteinsErbB ReceptorsFluorescent DyesRecombinant Fusion Proteins

Identifiers

PMID25490520
PMCPMC4306507
OpenAlexW2037383809

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.